PROCESSUS DE PRISE EN CHARGE THÉRAPEUTIQUE DU SYNDROME DE L'INTESTIN IRRITABLE À DOMINANCE DIARRHÉIQUE À L'AIDE DEBACILLUS
- 专利权人:
- Sami Labs Limited
- 发明人:
- 申请号：
- EP16884099.9
- 公开号：
- EP3240553A4
- 申请日:
- 2016.01.07
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要：
- The present invention discloses a process for the therapeutic management of diarrhea predominant irritable bowel syndrome in humans comprising the oral administration of Bacillus coagulans SBC37-01, MTCC 5856 (containing not less than 2 billion spores) along with standard treatment of care in a specific manner.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856
- PROCESS FOR THE THERAPEUTIC MANAGEMENT OF DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME USING BACILLUS COAGULANS SBC37-01, MTCC 5856
- PROCESS FOR THE THERAPEUTIC MANAGEMENT OF DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME USING BACILLUS COAGULANS SBC37-01, MTCC 5856
- SBC37-01 MTCC 5856 PROCESS FOR THE THERAPEUTIC MANAGEMENT OF DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME USING BACILLUS COAGULANS SBC37-01 MTCC 5856
- Process for the therapeutic management of Diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC-37-01, MTCC 5856
